Epilogue: the peril and the promise of comparative effectiveness research in oncology.
Publication
, Journal Article
Lyman, GH; Levine, M
Published in: J Clin Oncol
December 1, 2012
Duke Scholars
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
December 1, 2012
Volume
30
Issue
34
Start / End Page
4282
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Medical Oncology
- Humans
- Comparative Effectiveness Research
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., & Levine, M. (2012). Epilogue: the peril and the promise of comparative effectiveness research in oncology. J Clin Oncol, 30(34), 4282. https://doi.org/10.1200/JCO.2012.45.9800
Lyman, Gary H., and Mark Levine. “Epilogue: the peril and the promise of comparative effectiveness research in oncology.” J Clin Oncol 30, no. 34 (December 1, 2012): 4282. https://doi.org/10.1200/JCO.2012.45.9800.
Lyman GH, Levine M. Epilogue: the peril and the promise of comparative effectiveness research in oncology. J Clin Oncol. 2012 Dec 1;30(34):4282.
Lyman, Gary H., and Mark Levine. “Epilogue: the peril and the promise of comparative effectiveness research in oncology.” J Clin Oncol, vol. 30, no. 34, Dec. 2012, p. 4282. Pubmed, doi:10.1200/JCO.2012.45.9800.
Lyman GH, Levine M. Epilogue: the peril and the promise of comparative effectiveness research in oncology. J Clin Oncol. 2012 Dec 1;30(34):4282.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
December 1, 2012
Volume
30
Issue
34
Start / End Page
4282
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Medical Oncology
- Humans
- Comparative Effectiveness Research
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences